Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes

Matthew E Falagas1, Drosos E Karageorgopoulos, Patrice Nordmann

  • 1Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece.

Future Microbiology
|June 29, 2011
PubMed

Insights

Treatment options for carbapenemase-producing Enterobacteriaceae are limited. Colistin, tigecycline, and combination therapies show potential, but resistance and lack of clinical data require careful consideration for effective antimicrobial strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Carbapenemase-producing Enterobacteriaceae (CPE) are emerging global nosocomial pathogens.
  • These strains exhibit resistance to most available antimicrobials, complicating treatment.
  • Clinical data guiding optimal therapy for CPE infections are scarce.

Purpose of the Study:

  • To review current antimicrobial options for treating infections caused by carbapenemase-producing Enterobacteriaceae.
  • To evaluate the in vitro activity, resistance development, and potential clinical utility of various antimicrobial agents.
  • To discuss the role of combination therapy and emerging treatment strategies.

Main Methods:

  • Literature review of antimicrobial susceptibility data.
  • Analysis of pharmacokinetic/pharmacodynamic parameters.
  • Evaluation of synergy and resistance development.
  • Consideration of clinical experience with similar pathogens.

Main Results:

  • Colistin and tigecycline demonstrate in vitro activity but raise concerns about resistance.
  • Aminoglycosides, carbapenems, and aztreonam (for MBL producers) show variable activity.
  • Expanded-spectrum cephalosporins (e.g., ceftazidime) may be active against OXA-48 producers.
  • Fosfomycin may serve as a last-resort option in combination regimens.

Conclusions:

  • Monotherapy with current agents is not reliably supported for systemic CPE infections.
  • Combination antimicrobial therapy with synergistic agents may offer benefits.
  • Further research and novel agents are needed for effective treatment of CPE infections.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...